Stocks and Investing
Stocks and Investing
Mon, July 12, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sat, July 10, 2021
[ 12:00 AM ] - United States, WOPRAI
Brian Abrahams Maintained (VRTX) at Buy and Held Target at $246 on, Jul 10th, 2021
Brian Abrahams of RBC Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $246 on, Jul 10th, 2021.
Brian has made no other calls on VRTX in the last 4 months.
There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021
- Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $200 on, Monday, June 14th, 2021
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $205 on, Friday, June 11th, 2021
These are the ratings of the 10 analyists that currently disagree with Brian
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $261 on, Monday, June 14th, 2021
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $331 on, Monday, June 14th, 2021
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $307 on, Friday, June 11th, 2021
- Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $285 on, Friday, June 11th, 2021
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $244 on, Friday, June 11th, 2021
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $285 on, Friday, June 11th, 2021
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $281 on, Friday, June 11th, 2021
- Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $240 on, Friday, June 11th, 2021
- Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $260 on, Monday, May 3rd, 2021
Contributing Sources